Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 23, Issue 2, Pages 59-64
http://dx.doi.org/10.1155/2012/583630
Original Article

Economic Evaluation of Posaconazole Versus Standard Azole Therapy as Prophylaxis against Invasive Fungal Infections in Patients with Prolonged Neutropenia in Canada

Amir A Tahami Monfared,1 Amy K O’Sullivan,2 Coleman Rotstein,3 and George Papadopoulos4

1Merck & Co Inc, Kirkland, Quebec, Canada
2i3 Innovus, Medford, Massachusetts, USA
3University of Toronto, University Health Network, Toronto, Ontario, Canada
4Merck & Co Inc, Whitehouse Station, New Jersey, USA

Copyright © 2012 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Amir A Tahami Monfared, Amy K O’Sullivan, Coleman Rotstein, and George Papadopoulos, “Economic Evaluation of Posaconazole Versus Standard Azole Therapy as Prophylaxis against Invasive Fungal Infections in Patients with Prolonged Neutropenia in Canada,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 23, no. 2, pp. 59-64, 2012. https://doi.org/10.1155/2012/583630.